The FDA is issuing this letter to ensure you are aware of this defect and the recommended actions to take to manage the care of patients currently implanted with a Medtronic HVAD system.
Read more: Potential for Internal Pump Malfunction in the Medtronic HVAD System – Letter to Health Care Providers